Company record
ACCORD BIOPHARMA INC
0 FDA warning letters since 2023 and 1 recall in the last 12 months.
Get an email the day FDA posts anything new about ACCORD BIOPHARMA INC.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Jul 8 | Class II | ACCORD BIOPHARMA INC Drug |
IMULDOSA, (ustekinumab-srlf) Injection, 130 mg/26 mL (5mg/mL), Rx only, Single dose vial, Manufactured by Accord BioPharma Inc., 8041 Arco corporate Drive, Suite 200, Raleigh, NC 27617, USA, Manufactured at: Catalent Ind… Lack of assurance of Sterility: |